Administration of a drug promoting neuronal euchromatin formation ameliorated memory impairment and pathological hippocampal gene expression changes in a mouse model of heart failure.
Does a drug that promotes neuronal euchromatin formation improve memory function in mice with heart failure?
This study provides preclinical evidence that heart failure-induced cognitive defects are linked to epigenetic changes in the hippocampus, which can be ameliorated by drugs promoting neuronal euchromatin formation.
In current clinical practice, care of diseased patients is often restricted to separated disciplines. However, such an organ-centered approach is not always suitable. For example, cognitive dysfunction is a severe burden in heart failure patients. Moreover, these patients have an increased risk for age-associated dementias. The underlying molecular mechanisms are presently unknown, and thus, corresponding therapeutic strategies to improve cognition in heart failure patients are missing. Using mice as model organisms, we show that heart failure leads to specific changes in hippocampal gene expression, a brain region intimately linked to cognition. These changes reflect increased cellular stress pathways which eventually lead to loss of neuronal euchromatin and reduced expression of a hippocampal gene cluster essential for cognition. Consequently, mice suffering from heart failure exhibit impaired memory function. These pathological changes are ameliorated via the administration of a drug that promotes neuronal euchromatin formation. Our study provides first insight to the molecular processes by which heart failure contributes to neuronal dysfunction and point to novel therapeutic avenues to treat cognitive defects in heart failure patients.
Islam et al. (Wed,) conducted a other in Heart failure and memory impairment. Drug that promotes neuronal euchromatin formation was evaluated on Hippocampal gene expression and memory function. Administration of a drug promoting neuronal euchromatin formation ameliorated memory impairment and pathological hippocampal gene expression changes in a mouse model of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: